TMO – Thermo Fisher Scientific Inc.
Float Short %
1.05
Margin Of Safety %
-1
Put/Call OI Ratio
0.73
EPS Next Q Diff
1.14
EPS Last/This Y
0.64
EPS This/Next Y
1.94
Price
479.5
Target Price
544.96
Analyst Recom
1.61
Performance Q
15.44
Relative Volume
0.62
Beta
0.78
Ticker: TMO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | TMO | 489.18 | 0.70 | 0.11 | 107992 |
| 2025-08-18 | TMO | 487.77 | 0.71 | 1.08 | 98713 |
| 2025-08-19 | TMO | 498.39 | 0.71 | 0.71 | 99612 |
| 2025-08-20 | TMO | 494.82 | 0.71 | 1.12 | 100360 |
| 2025-08-21 | TMO | 483.6 | 0.72 | 2.14 | 101721 |
| 2025-08-22 | TMO | 500.36 | 0.72 | 0.49 | 102090 |
| 2025-08-25 | TMO | 490.56 | 0.71 | 1.07 | 100575 |
| 2025-08-26 | TMO | 488.54 | 0.72 | 0.93 | 101115 |
| 2025-08-27 | TMO | 487.98 | 0.71 | 1.63 | 101580 |
| 2025-08-28 | TMO | 490.05 | 0.71 | 0.95 | 102879 |
| 2025-08-29 | TMO | 492.83 | 0.71 | 0.74 | 103228 |
| 2025-09-02 | TMO | 487.54 | 0.71 | 1.61 | 102604 |
| 2025-09-03 | TMO | 484.47 | 0.71 | 3.31 | 103252 |
| 2025-09-04 | TMO | 489.45 | 0.72 | 4.94 | 103573 |
| 2025-09-05 | TMO | 492.59 | 0.72 | 0.60 | 104398 |
| 2025-09-08 | TMO | 487.64 | 0.72 | 1.52 | 102475 |
| 2025-09-09 | TMO | 482.63 | 0.73 | 1.36 | 103036 |
| 2025-09-10 | TMO | 476.35 | 0.73 | 0.63 | 104192 |
| 2025-09-11 | TMO | 491.31 | 0.73 | 1.43 | 104623 |
| 2025-09-12 | TMO | 479.54 | 0.73 | 1.36 | 104893 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | TMO | 489.26 | 4.3 | 1560.7 | 22.49 |
| 2025-08-18 | TMO | 487.70 | 4.3 | 1463.6 | 22.49 |
| 2025-08-19 | TMO | 498.29 | 4.3 | 1674.8 | 22.49 |
| 2025-08-20 | TMO | 494.92 | 4.3 | 1428.5 | 22.49 |
| 2025-08-21 | TMO | 483.83 | 4.3 | 1296.6 | 22.49 |
| 2025-08-22 | TMO | 500.11 | 4.3 | 1774.7 | 22.49 |
| 2025-08-25 | TMO | 490.59 | 4.2 | 1325.4 | 22.49 |
| 2025-08-26 | TMO | 488.48 | 4.2 | 1447.0 | 22.49 |
| 2025-08-27 | TMO | 488.10 | 4.2 | 1479.8 | 22.49 |
| 2025-08-28 | TMO | 490.07 | 4.2 | 1520.6 | 22.49 |
| 2025-08-29 | TMO | 492.98 | 4.2 | 1542.9 | 22.49 |
| 2025-09-02 | TMO | 487.38 | 4.3 | 1393.8 | 22.50 |
| 2025-09-03 | TMO | 484.63 | 4.3 | 2073.7 | 22.50 |
| 2025-09-04 | TMO | 489.50 | 4.3 | 2220.7 | 22.50 |
| 2025-09-05 | TMO | 492.60 | 4.3 | 2185.6 | 22.50 |
| 2025-09-08 | TMO | 487.65 | 4.2 | 2036.3 | 22.50 |
| 2025-09-09 | TMO | 482.55 | 4.2 | 2032.7 | 22.50 |
| 2025-09-10 | TMO | 476.47 | 4.2 | 2016.0 | 22.50 |
| 2025-09-11 | TMO | 491.41 | 4.2 | 2410.7 | 22.50 |
| 2025-09-12 | TMO | 479.50 | 4.2 | 1908.1 | 22.50 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | TMO | -8.67 | -0.24 | 0.98 |
| 2025-08-18 | TMO | -8.67 | -0.02 | 0.98 |
| 2025-08-19 | TMO | -8.67 | -0.02 | 0.98 |
| 2025-08-20 | TMO | -8.67 | -0.02 | 0.98 |
| 2025-08-21 | TMO | -8.74 | -0.02 | 0.98 |
| 2025-08-22 | TMO | -8.74 | -0.02 | 0.98 |
| 2025-08-25 | TMO | -8.74 | -0.98 | 0.98 |
| 2025-08-26 | TMO | -7.65 | -0.98 | 0.98 |
| 2025-08-27 | TMO | -7.65 | -0.98 | 1.01 |
| 2025-08-28 | TMO | -7.65 | -0.98 | 1.01 |
| 2025-08-29 | TMO | -7.65 | -0.98 | 1.01 |
| 2025-09-02 | TMO | -7.65 | -1.18 | 1.01 |
| 2025-09-03 | TMO | -7.70 | -1.18 | 1.01 |
| 2025-09-04 | TMO | -7.70 | -1.18 | 1.01 |
| 2025-09-05 | TMO | -7.46 | -1.18 | 1.01 |
| 2025-09-08 | TMO | -5.00 | -1.21 | 1.01 |
| 2025-09-09 | TMO | -5.35 | -1.21 | 1.01 |
| 2025-09-10 | TMO | -5.35 | -1.21 | 1.01 |
| 2025-09-11 | TMO | -5.35 | -1.21 | 1.05 |
| 2025-09-12 | TMO | -4.79 | -1.21 | 1.05 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
5.36
Avg. EPS Est. Current Quarter
5.5
Avg. EPS Est. Next Quarter
6.5
Insider Transactions
-4.79
Institutional Transactions
-1.21
Beta
0.78
Average Sales Estimate Current Quarter
10896
Average Sales Estimate Next Quarter
11778
Fair Value
474.44
Quality Score
82
Growth Score
81
Sentiment Score
49
Actual DrawDown %
28.7
Max Drawdown 5-Year %
-41
Target Price
544.96
P/E
27.75
Forward P/E
19.68
PEG
3.88
P/S
4.19
P/B
3.58
P/Free Cash Flow
29.34
EPS
17.28
Average EPS Est. Cur. Y
22.5
EPS Next Y. (Est.)
24.44
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
15.24
Relative Volume
0.62
Return on Equity vs Sector %
-11.8
Return on Equity vs Industry %
2.2
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
1908.1
Thermo Fisher Scientific IncSector: Healthcare
Industry: Diagnostics & Research
Employees: 125000
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
stock quote shares TMO – Thermo Fisher Scientific Inc. Stock Price stock today
news today TMO – Thermo Fisher Scientific Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TMO – Thermo Fisher Scientific Inc. yahoo finance google finance
stock history TMO – Thermo Fisher Scientific Inc. invest stock market
stock prices TMO premarket after hours
ticker TMO fair value insiders trading